HFA
NVO

Hoover Financial Advisors’s Novo Nordisk NVO Stock Holding History

Hoover Financial Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$42K Hold
1,000
– – 0.01% 301
2021
Q1 		$38K Buy
+1,000
New +$35.6K 0.01% 285

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Hoover Financial Advisors's NVO Position: Q2 2021 in Review

Hoover Financial Advisors held its Novo Nordisk (NVO) position steady in Q2 2021 at 1,000 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #301.

Hoover Financial Advisors first reported a position in NVO in Q1 2021 and has held it in 2 quarters since. 736 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Hoover Financial Advisors held 1,000 shares of Novo Nordisk worth $42K as of Q2 2021.
  • Hoover Financial Advisors left its Novo Nordisk share count unchanged in Q2 2021.
  • Novo Nordisk made up 0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #301 holding.
  • Hoover Financial Advisors first reported a position in Novo Nordisk in Q1 2021 and has held it in 2 quarters since.
  • 736 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.